ArticleChinese medical journal2025

Olaparib and niraparib as maintenance therapy in patients with newly diagnosed and platinum-sensitive recurrent ovarian cancer: A single-center study in China.

Dengfeng Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.